GBM
Clinical trials for GBM explained in plain language.
Never miss a new study
Get alerted when new GBM trials appear
Sign up with your email to follow new studies for GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer that had returned after standard treatments. The trial aimed to see if VAL-083 could help patients live longer. However, the study was stopped early after only 2 people enrolled, s…
Matched conditions: GBM
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:46 UTC
-
Brain tumor drug penetration study halted early
Knowledge-focused TerminatedThis early-phase trial aimed to measure how much of the drug infigratinib reaches brain tumor tissue in people with recurrent high-grade glioma (a type of brain cancer). Only 7 participants were enrolled before the study was terminated. The main goal was to check drug levels in t…
Matched conditions: GBM
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC